Dr Melanie Lee

Executive Vice President R&D

Melanie Lee has been Executive Vice President of R&D since 2004, responsible for Japan, US, Belgium and UK. She joined Celltech as Executive Research Director in 1998.   Prior to Celltech she led the G-protein coupled receptor molecular pharmacology department at GlaxoSmithKline.

Melanie is Chairman of Cancer Research Technology, the wholly owned technology development and licensing subsidiary of Cancer Research UK and a Trustee of the Charity.  She is a Trustee of The Centre of the Cell (an interactive science education centre, of the St Bart's and Royal London hospitals, London) and a member of the Cambridge University scientific advisory board.  She has been awarded an Honorary Doctorate from York University and is a member of the York University Development Board. She is a member of the BBSRC review panel for Systems Biology in the UK.

She received a Bachelor's Degree in Biology at York University and a PhD at the National Institute for Medical Research (MRC, London) with Professor Robin Holliday. She undertook two postdoctoral positions at Imperial College, London with Professor Jean Beggs and at the Imperial Cancer Research Fund, London with Sir Paul Nurse, and is recognised for her contribution to Sir Paul Nurse' Nobel Prize winning work.